Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
2.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
3.
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
4.
Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
5.
Commercial and Pipeline Insight: HRT for Menopausal Symptoms A new class restores an old market
6.
Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
7.
Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
8.
Stakeholder Opinions: Heart Failure - When drugs do not work
9.
Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
10.
Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
Best Sellers:
1.
Primary Brain Cancer
2.
Drug Delivery Global Industry Guide
3.
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
4.
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
5.
BioNewsCast Press Release Distribution Service
6.
Pharmaceutical Growth Opportunities in Brazil, Russia, India and China - Healthcare reform, market dynamics and key players
7.
Cell Therapy - Technologies, Markets and Companies
8.
Cytogenetics - technologies, markets and companies
9.
Molecular Diagnostics Markets
10.
The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis
Industry Report on Pharmaceutically-Relevant Target Classes
by Enal S. Razvi, Ph.D.
Published: August, 2006
This report focuses on two key pharmaceutical target classes-GPCRs and Ion Channels. GPCRs and Ion Channels are important targets. They are associated with a number of disease areas and are currently associated with blockbuster pharmaceutical sales status.
Identifying future direction of industry growth opportunities in these spaces can be challenging. This report characterizes the opportunity in the GPCR and Ion Channel spaces with respect to the following metrics:
> Technologies for interrogation
> Major Products on the market
> Vendors in the space
> Market opportunity, size, and growth (both qualitative and quantitative)
This report draws upon a proprietary end-user survey conducted by D&MD to assess both the qualitative and quantitative market opportunity in the GPCRs and Ion Channels spaces. The raw data and annotations of these data are presented in this industry report and provide a snapshot into the direction of this market. This report also includes a SWOT analysis of the key market participants, which serves to complement the qualitative and quantitative analysis by offering a glimpse into the scope of opportunity in various niches.
Buy this report and:
> Identify qualitative trends-market drivers, market challenges, bottlenecks, opportunities-in the GPCRs and Ion Channels market segments
> Examine thorough quantitative analysis: market size, market shares of the various companies/technologies, and a cost per assay point, screening metrics
> Gain insight into growth opportunities for tools developers to develop reagents, technologies, hardware/instrumentation to address the growth in the GPCR and Ion Channels spaces
Aug-06 Pages 100
The Author
Price
PDF $4,950.00
Printed $5,150.00
CD-ROM $5,150.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.